CA2352388A1 - A pharmaceutical composition comprising cyclosporin in a lipid carrier - Google Patents

A pharmaceutical composition comprising cyclosporin in a lipid carrier Download PDF

Info

Publication number
CA2352388A1
CA2352388A1 CA002352388A CA2352388A CA2352388A1 CA 2352388 A1 CA2352388 A1 CA 2352388A1 CA 002352388 A CA002352388 A CA 002352388A CA 2352388 A CA2352388 A CA 2352388A CA 2352388 A1 CA2352388 A1 CA 2352388A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
cyclosporin
lipids
monoglycerides
cyclosporine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002352388A
Other languages
English (en)
French (fr)
Inventor
Bengt Herslof
Peter Kaufmann
Carl-Gunnar Kroon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIPOCORE HOLDING AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2352388A1 publication Critical patent/CA2352388A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA002352388A 1998-12-03 1999-12-03 A pharmaceutical composition comprising cyclosporin in a lipid carrier Abandoned CA2352388A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9804192-4 1998-12-03
SE9804192A SE9804192D0 (sv) 1998-12-03 1998-12-03 New formulation
PCT/SE1999/002259 WO2000032219A1 (en) 1998-12-03 1999-12-03 A pharmaceutical composition comprising cyclosporin in a lipid carrier

Publications (1)

Publication Number Publication Date
CA2352388A1 true CA2352388A1 (en) 2000-06-08

Family

ID=20413540

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002352388A Abandoned CA2352388A1 (en) 1998-12-03 1999-12-03 A pharmaceutical composition comprising cyclosporin in a lipid carrier

Country Status (10)

Country Link
EP (1) EP1135152A1 (de)
JP (1) JP2002531412A (de)
AU (1) AU764413B2 (de)
CA (1) CA2352388A1 (de)
HU (1) HUP0105399A3 (de)
NO (1) NO20012736D0 (de)
NZ (1) NZ512194A (de)
PL (1) PL348062A1 (de)
SE (1) SE9804192D0 (de)
WO (1) WO2000032219A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
SE0303135D0 (sv) * 2003-11-25 2003-11-25 Lipocore Holding Ab Controlled food effect composition
SE0401942D0 (sv) * 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
CA2607738A1 (en) * 2005-04-28 2006-11-02 Galenica Technology Ab Pharmaceutical dosage forms comprising a lipid phase
US20140044779A1 (en) * 2011-04-18 2014-02-13 Lipidor Ab Liquid Carrier for Oral Delivery of a Pharmacologically Active Agent
WO2014103742A1 (ja) * 2012-12-25 2014-07-03 ポーラ化成工業株式会社 逆ベシクル組成物及びその製造方法
JP6242582B2 (ja) * 2013-04-01 2017-12-06 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法
JP6242581B2 (ja) * 2013-04-01 2017-12-06 ポーラ化成工業株式会社 逆ベシクル組成物の製造方法
JP6334151B2 (ja) * 2012-12-25 2018-05-30 ポーラ化成工業株式会社 逆ベシクル組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US5529785A (en) * 1993-05-12 1996-06-25 Dietl; Hans Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
CN1091591C (zh) * 1994-02-04 2002-10-02 利珀克尔集团公司 亲脂载体制剂
IL129547A (en) * 1994-10-26 2001-01-11 Novartis Ag Pharmaceutical compositions comprising a macrolide and an acid
IT1289939B1 (it) * 1997-02-20 1998-10-19 Angelini Ricerche Spa Composizione farmaceutica acquosa comprendente un principio attivo altamente insolubile in acqua
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition

Also Published As

Publication number Publication date
WO2000032219A1 (en) 2000-06-08
NO20012736L (no) 2001-06-01
AU764413B2 (en) 2003-08-21
NO20012736D0 (no) 2001-06-01
SE9804192D0 (sv) 1998-12-03
HUP0105399A3 (en) 2005-06-28
NZ512194A (en) 2002-09-27
EP1135152A1 (de) 2001-09-26
PL348062A1 (en) 2002-05-06
HUP0105399A2 (en) 2002-06-29
AU2016700A (en) 2000-06-19
JP2002531412A (ja) 2002-09-24

Similar Documents

Publication Publication Date Title
AU691250B2 (en) Lipophilic carrier preparations
CN1048182C (zh) 脂肪乳药物载体的制备方法
KR100193980B1 (ko) 수중유 유화액
ES2249797T3 (es) Composiciones de lipidos solidos de componentes lipofilicos para mejorar la biodisponibilidad oral.
US5665379A (en) Lipid particle forming matrix, preparation and use thereof
FI111130B (fi) Menetelmä syklosporiinijohdannaista sisältävän farmaseuttisen koostumuksen valmistamiseksi
KR20000022353A (ko) 중간쇄 모노글리세리드를 함유한 소수성 조제
CN107405326A (zh) ω3脂肪酸的自乳化组合物
PL178438B1 (pl) Preparat dwuwarstwy lipidowej, środek farmaceutyczny zawierający preparat dwuwarstwy lipidowej i sposób wytwarzania środka farmaceutycznego
CA2612128C (en) Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients
EP0514506B1 (de) System auf basis einer lipidformulierung
JPH02203A (ja) 薬物担体
AU764413B2 (en) A pharmaceutical composition comprising cyclosporin in a lipid carrier
KR20070058608A (ko) 항미생물 방부 효능을 갖는 정맥 내 투여를 위한 안정한에멀젼 조성물
US20080064760A1 (en) Spontaneously Dispersible Pharmaceutical Composition
UA57725C2 (uk) Композиція, що містить циклоспорин, спосіб одержання желатинових капсул, що містять циклоспорин, та спосіб лікування станів чи симптомів з його використанням
AU2015354848B2 (en) Formulation for effective tocotrienol delivery
EP0385445A2 (de) Verfahren zur Herstellung einer Suspension sowie das auf diese Weise hergestellte Mittel
KR20040047056A (ko) 비페닐디메틸디카복실레이트의 경구용 마이크로에멀젼조성물
KR20050011323A (ko) 자가미세유화형 약물전달시스템을 이용한 고지혈증치료용약제 조성물
ZA200300330B (en) Amphotericin B Structured emulsion.
RU2127124C1 (ru) Препараты липофильных носителей
WO2003020318A1 (en) A topical w/o-emulsion composition
JPH01307437A (ja) 安全でかつ高度な界面活性を有する脂質組成物

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20051205